Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDIO | Common Stock | Options Exercise | $4K | +1.61K | +1.91% | $2.49 | 85.6K | Dec 31, 2023 | Direct | F1 |
transaction | CDIO | Common Stock | Options Exercise | $12.5K | +5.02K | +5.87% | $2.49 | 90.6K | Dec 31, 2023 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDIO | Restricted Stock Units | Options Exercise | -$4K | $2K | Dec 31, 2023 | Common Stock | $4K | $0.00 | Direct | F3, F4, F6 | |||
transaction | CDIO | Restricted Stock Units | Options Exercise | -$12.5K | $0 | Dec 31, 2023 | Common Stock | $12.5K | $0.00 | Direct | F3, F5, F6 |
Id | Content |
---|---|
F1 | Represents the settlement of restricted stock units (RSUs), awarded for advisory services, which vested on December 31, 2023 through the issuance of shares of Common Stock. |
F2 | Represents the settlement of RSUs, awarded as director compensation, which vested on December 31, 2023 through the issuance of shares of Common Stock. |
F3 | Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On December 31, 2023, $14,500 in value of RSUs vested and were settled at the price of $2.49, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I. |
F4 | On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $4,000 in value of which vested on December 31, 2023. Subject to continued service with the Issuer on the vesting date, $2,000 in value of RSUs will vest on January 31, 2024. |
F5 | On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs of which $12,500 vested on December 31, 2023. |
F6 | The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan. |